Prothena Corporation plc provided earnings guidance for the year 2024. The company expects full year 2024 net cash used in operating and investing activities to be between $208 million and $225 million. The estimated full year 2024 net cash used in operating and investing activities is primarily driven by an estimated net loss of $229 million to $255 million, which includes an estimated $51 million of noncash share-based compensation expense.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.34 USD | -3.00% | -6.93% | -41.28% |
09/05 | RBC Cuts Price Target on Prothena to $28 From $35, Keeps Sector Perform, Speculative Risk | MT |
08/05 | Earnings Flash (PRTA) PROTHENA CORPORATION Posts Q1 Revenue $50,000 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.28% | 1.15B | |
+3.91% | 109B | |
+10.87% | 105B | |
-0.26% | 22.25B | |
-13.14% | 22.09B | |
-8.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- PRTA Stock
- News Prothena Corporation plc
- Prothena Corporation plc Provides Earnings Guidance for the Year 2024